RS
Rajni Surana
About Rajni Surana
Data last updated:
Rajni Surana is a Director at Raja Antibiotics Limited (since 2016) and Designated Partner at Arhamantriksh Pharma Llp (since 2026). The companies operate in Pharma. The largest current company by reported revenue is Raja Antibiotics Limited at ₹4.46 Cr (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Raja Antibiotics Limited U24233MH1995PLC091177 | Director | 29 Aug 2016 | 1995 | ₹4.46 Cr (FY 2019) | Active |
| Arhamantriksh Pharma Llp ACU-6312 | Designated Partner | 22 Jan 2026 | 2026 | Inactive For E-Filing |
Board colleagues of Rajni Surana
| Name | DIN | Company | Designation |
|---|---|---|---|
| Satish Surana | 00530283 | Raja Antibiotics Limited | Director |
| Sushil Nainmal Surana | 00665671 | Raja Antibiotics Limited | Director |
| Nitin Prakash Lodha | 08238390 | Arhamantriksh Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajni Surana
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajni Surana
Rajni Surana currently holds 2 directorships: Raja Antibiotics Limited (Director, since 29 Aug 2016, revenue ₹4.46 Cr (FY 2019)); Arhamantriksh Pharma Llp (Designated Partner, since 22 Jan 2026).
Rajni Surana was first appointed on 29 Aug 2016 as Director at Raja Antibiotics Limited. The most recent appointment on record is 22 Jan 2026 at Arhamantriksh Pharma Llp.
The current boards of Rajni Surana's companies include Satish Surana (Raja Antibiotics Limited), Sushil Nainmal Surana (Raja Antibiotics Limited), Nitin Prakash Lodha (Arhamantriksh Pharma Llp).